GYLDEN PHARMA LIMITED Financials
- Company number
- 09955881Copy
Copy - Registered office
- 4 & 5 Dunmore Court Wootton Road, Abingdon, Oxfordshire OX13 6BH
- Incorporated
- 18/01/2016
Company snapshot
- Status
- Active
- Employees
- 36 (2025)
- Latest financial data
- 2025
- Accounts type
- Unaudited abridged
Financial highlights
Latest reported figures. Okredo holds filed data for 2023–2025.
Net Assets
-214.86%vs 20242024: £2.91M
Total Assets
-65.95%vs 20242024: £7.80M
Cash in Bank
-36.67%vs 20242024: £464.85K
Total Liabilities
48.66%vs 20242024: £3.55M
Employees
-3vs 20242024: 39
In 2025, GYLDEN PHARMA LIMITED reported net assets of £-3.34M. The same filing shows total assets of £2.66M, cash in bank of £294.38K and total liabilities of £5.28M. Reported headcount was 36 in 2025. Net Assets fell from £2.91M in 2024 to £-3.34M in 2025 (-214.86%). Okredo holds filed figures for 2023–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
-214.86%from £2.91M in 2024Year-on-year change
Net Assets as filed for 2023–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures GYLDEN PHARMA LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
-149%vs 2023Cash in Bank
-87.9%vs 2023-65.2% a year compound (CAGR)
Total Assets
-82.5%vs 2023-58.1% a year compound (CAGR)
Total Liabilities
+30.3%vs 2023+14.1% a year compound (CAGR)
Employees
+2.9%vs 2023+1Biggest increase
Total Liabilities+30.3%
£4.05M in 2023 to £5.28M in 2025
Biggest decrease
Net Assets-149%
£6.86M in 2023 to £-3.34M in 2025
GYLDEN PHARMA LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in total liabilities, pointing to heavier outstanding obligations, set against a fall in net assets, pointing to a weakening balance sheet. See the full year-by-year figures.
Ratios from the filed figures
Calculated from GYLDEN PHARMA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- -125.62%2025
- Liabilities to total assets
- 198.80%2025
- Cash to liabilities
- 5.57%2025
- Cash to total assets
- 11.08%2025
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for GYLDEN PHARMA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Assets£ | 6.86M | 2.91M | -3.34M |
| Total Assets£ | 15.14M | 7.80M | 2.66M |
| Cash in Bank£ | 2.43M | 464.85K | 294.38K |
| Total Liabilities£ | 4.05M | 3.55M | 5.28M |
| Employees | 35 | 39 | 36 |
GYLDEN PHARMA LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Has GYLDEN PHARMA LIMITED filed financial statements?
Yes. Okredo holds filed figures for GYLDEN PHARMA LIMITED covering 2023–2025, across 5 reported indicators. The most recent reported year is 2025.
What net assets did GYLDEN PHARMA LIMITED report in 2025?
GYLDEN PHARMA LIMITED reported net assets of £-3.34M for 2025. That compares with £2.91M in 2024, a change of -214.86%.
What total assets did GYLDEN PHARMA LIMITED report in 2025?
GYLDEN PHARMA LIMITED reported total assets of £2.66M for 2025. That compares with £7.80M in 2024, a change of -65.95%.
What cash in bank did GYLDEN PHARMA LIMITED report in 2025?
GYLDEN PHARMA LIMITED reported cash in bank of £294.38K for 2025. That compares with £464.85K in 2024, a change of -36.67%.
How many people does GYLDEN PHARMA LIMITED employ?
GYLDEN PHARMA LIMITED reported 36 employees in 2025, compared with 39 in 2024.
How have GYLDEN PHARMA LIMITED financials changed over the last 3 years?
Between 2023 and 2025, GYLDEN PHARMA LIMITED's net assets fell by 149%, cash in bank fell by 87.9%, total assets fell by 82.5% and total liabilities rose by 30.3%. Cash in bank contracted at 65.2% a year across the two years to 2025, from £2.43M to £294.38K. Reported headcount went from 35 in 2023 to 36 in 2025 (+1).
Which years of GYLDEN PHARMA LIMITED financial data are available?
Okredo holds reported figures for the years 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.